Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group

被引：0
|
作者：
Fountzilas, E. [1 ]
Lalla, T. [1 ]
Karakatsoulis, G. [1 ]
Papazisis, K. [1 ]
Exarchos, K. [1 ]
Koumarianou, A. [1 ]
Nikolaidi, A. [1 ]
Binas, I. [1 ]
Mauri, D. [1 ]
Karageorgopoulou, S. [1 ]
Razis, E. [1 ]
Christopoulou, A. [1 ]
Boutis, A. [1 ]
Douganiotis, G. [1 ]
Zagouri, F. [1 ]
Stamatopoulou, S. [1 ]
Spathas, N. [1 ]
Tryfonopoulos, D. [1 ]
Psyrri, A. [1 ]
Koutras, A. [1 ]
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Data Off, Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113954
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3LBA
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
    Elena Fountzilas
    Sofia Lampaki
    Georgia-Angeliki Koliou
    Anna Koumarianou
    Sofia Levva
    Anastasios Vagionas
    Athina Christopoulou
    Athanasios Laloysis
    Amanda Psyrri
    Ioannis Binas
    Giannis Mountzios
    Nikolaos Kentepozidis
    Athanassios Kotsakis
    Emmanouil Saloustros
    Anastasios Boutis
    Adamantia Nikolaidi
    George Fountzilas
    Vassilis Georgoulias
    Miltiadis Chrysanthidis
    Elias Kotteas
    Henry Vo
    Marinos Tsiatas
    Eleni Res
    Helena Linardou
    Dimitrios Daoussis
    Iliada Bompolaki
    Anna Andreadou
    George Papaxoinis
    Dionisios Spyratos
    Helen Gogas
    Konstantinos N. Syrigos
    Dimitrios Bafaloukos
    Cancer Immunology, Immunotherapy, 2022, 71 : 327 - 337
  • [2] Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
    Fountzilas, Elena
    Lampaki, Sofia
    Koliou, Georgia-Angeliki
    Koumarianou, Anna
    Levva, Sofia
    Vagionas, Anastasios
    Christopoulou, Athina
    Laloysis, Athanasios
    Psyrri, Amanda
    Binas, Ioannis
    Mountzios, Giannis
    Kentepozidis, Nikolaos
    Kotsakis, Athanassios
    Saloustros, Emmanouil
    Boutis, Anastasios
    Nikolaidi, Adamantia
    Fountzilas, George
    Georgoulias, Vassilis
    Chrysanthidis, Miltiadis
    Kotteas, Elias
    Vo, Henry
    Tsiatas, Marinos
    Res, Eleni
    Linardou, Helena
    Daoussis, Dimitrios
    Bompolaki, Iliada
    Andreadou, Anna
    Papaxoinis, George
    Spyratos, Dionisios
    Gogas, Helen
    Syrigos, Konstantinos N.
    Bafaloukos, Dimitrios
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (02) : 327 - 337
  • [3] The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patientsda multicenter real-world analysis
    Dannehl, D.
    Jakob, D.
    Mergel, F.
    Estler, A.
    Engler, T.
    Volmer, L.
    Frevert, M-L
    Matovina, S.
    Englisch, A.
    Tegeler, C. M.
    Rohner, A.
    Seller, A.
    Hahn, M.
    Pfister, K.
    Fink, A.
    Popp, I.
    Lorenz, S.
    Tabatabai, G.
    Juhasz-Boess, I.
    Janni, W.
    Brucker, S.
    Taran, F. -A
    Hartkopf, A.
    Schaeffler, H.
    ESMO OPEN, 2024, 9 (05)
  • [4] Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Mai, Nicholas
    Klar, Miriam
    Ferraro, Emanuela
    Bromberg, Maria
    Chen, Yuan
    Razavi, Pedram
    Modi, Shanu
    Chandarlapaty, Sarat
    Walsh, Elaine M.
    Drago, Joshua Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Real-world outcomes of sacituzumab govitecan in breast cancer
    Singh, Vaishnavi
    Dhaibar, Hemangini
    Peddi, Prakash
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Efficacy and safety of Trastuzumab Deruxtecan Therapy: Analysis of real-world data
    Nina, Privsek
    Simona, Borstnar
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2024, 28 (02) : 30 - 39
  • [7] SACITUZUMAB GOVITECAN - REAL-WORLD EXPERIENCE OF A PORTUGUESE CANCER CENTER
    Cabral, Sara
    Pereira, Carolina
    Cardoso, Catarina
    Gouveia, Emanuel
    Nunes, Hugo
    Pereira, Patricia
    Brito, Margarida
    BREAST, 2023, 71 : S61 - S61
  • [8] Real-world activity of sacituzumab govitecan for metastatic breast cancer
    Morganti, S.
    Kusmick, R.
    Hughes, M. E.
    Braso-Maristany, F.
    Smith, K.
    Tarantino, P.
    Vega Leon, M. D. R.
    Grinda, T.
    Pardo, F.
    Dvir, K.
    Suggs, G.
    Buck, S.
    Skeffington, M.
    Garrido-Castro, A. C.
    Parsons, H.
    Sammons, S.
    Prat, A.
    Lin, N.
    Tolaney, S. M.
    Giordano, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S382 - S382
  • [9] Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
    Poumeaud, F.
    Morisseau, M.
    Cabel, L.
    Goncalves, A.
    Rivier, C.
    Tredan, O.
    Volant, E.
    Frenel, J. -s.
    Ladoire, S.
    Jacot, W.
    Jamelot, M.
    Foka Tichoue, H.
    Patsouris, A.
    Teixeira, L.
    Bidard, F. -c.
    Loirat, D.
    Brunet, M.
    Levy, C.
    Bailleux, C.
    Cabarrou, B.
    Deleuze, A.
    Uwer, L.
    Deluche, E.
    Grellety, T.
    Franchet, C.
    Fiteni, F.
    Bischoff, H.
    Vion, R.
    Pagliuca, M.
    Verret, B.
    Becourt, S.
    Reverdy, T.
    de Nonneville, A.
    Dalenc, F.
    BRITISH JOURNAL OF CANCER, 2024, 131 (04) : 702 - 708
  • [10] Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study
    Dulgar, Ozgecan
    Turker, Sema
    Basaran, Gul
    Araz, Murat
    Sumbul, Ahmet Taner
    Caglayan, Dilek
    Gumusay, Ozge
    Biter, Sedat
    Konca, Ahmet
    Ozen, Mirac
    Demir, Hacer
    Ozdemir, Melek
    Karatas, Fatih
    Sahin, Elif
    Cavdar, Eyyup
    Yasin, Ayse Irem
    Yasar, Alper
    Derin, Suemeyra
    Pehlivan, Metin
    Uyeturk, Ummugul
    Ozdemir, Ozlem
    Kayikcioglu, Erkan
    Ak, Naziye
    Sakalar, Teoman
    Sakin, Abdullah
    Buyuksimsek, Mahmut
    Ay, Seval
    Erturk, Ismail
    Akbas, Sinem
    Yucel, Kadriye Bir
    Gumus, Mahmut
    JOURNAL OF CHEMOTHERAPY, 2024,
12345